datalabs-logo

  • Ask Datalabs
  • My Feed
  • Companies
  • Investors
  • People
  • Funding Rounds
  • Acquisitions

  • Research Reports
  • Industries
  • Locations
Hummsa Biotech-logo
Hummsa Biotech
Hummsa Biotech-logoHummsa Biotech-logo
Hummsa Biotech

Hummsa Biotech - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

HUMMSA BIOTECH PRIVATE LIMITED
HUMMSA BIOTECH PRIVATE LIMITED
2022
2022

Founded in 2022, Hummsa Biotech operates in Health Tech offering a pipeline of oral, small-molecule therapies aimed at reshaping the management of metabolic and age-related diseases. The company focus...

Funding stage:

Pre-Seed

Last funding:

31/05/2024

Total funding:

$314.77K+

Revenue:

₹19.1K+ (FY25)

Investors

Employee count:

2

Last 90d

2

Last 90d

Hummsa Biotech: Financial Breakdown

Decoding financial health metrics of Hummsa Biotech

  • total_revenue_logo
    Total Revenue
    ₹19.1K
    -5%

    Prev. FY

  • total_expenses_logo
    Total Expenses
    ₹68.4 Lakh
    364%

    Prev. FY

  • profit_after_tax_logo
    Profit After Tax
    ₹-68.2 Lakh
    -371%

    Prev. FY

  • total_assets_logo
    Total Assets
    ₹1.4 Cr
    15%

    Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of Hummsa Biotech

No. In FY25, Hummsa Biotech reported a net loss of ₹68.2 Lakh, so it was not profitable.

Hummsa Biotech's revenue declined 4.5% year-on-year, from ₹20.0K in FY24 to ₹19.1K in FY25.

In FY25, Hummsa Biotech posted revenue of ₹19.1K (down 4.5% YoY) and a net loss of ₹68.2 Lakh. Explore the full financials of Hummsa Biotech here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

MY FEEDDISCOVERRESEARCH